|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
3
|
Van Cutsem E, Cervantes A and Nordlinger
B: Metastatic colorectal cancer: ESMO Clinical Practice Guidelines
for diagnosis, treatment and follow-up. Ann Oncol. 25(Suppl 3):
iii1–iii9. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Petri A, Lindow M and Kauppinen S:
MicroRNA silencing in primates: Towards development of novel
therapeutics. Cancer Res. 69:393–395. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Landi MT, Zhao Y, Rotunno M, Koshiol J,
Liu H, Bergen AW, Rubagotti M, Goldstein AM, Linnoila I, Marincola
FM, et al: MicroRNA expression differentiates histology and
predicts survival of lung cancer. Clin Cancer Res. 16:430–441.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Loo JM, Scherl A, Nguyen A, Man FY,
Weinberg E, Zeng Z, Saltz L, Paty PB and Tavazoie SF: Extracellular
metabolic energetics can promote cancer progression. Cell.
160:393–406. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen WQ, Hu L, Chen GX and Deng HX: Role
of microRNA-7 in digestive system malignancy. World J Gastrointest
Oncol. 8:121–127. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Suto T, Yokobori T, Yajima R, Morita H,
Fujii T, Yamaguchi S, Altan B, Tsutsumi S, Asao T and Kuwano H:
MicroRNA-7 expression in colorectal cancer is associated with poor
prognosis and regulates cetuximab sensitivity via EGFR regulation.
Carcinogenesis. 36:338–345. 2015. View Article : Google Scholar
|
|
11
|
Li Y, Li Y, Liu Y, Xie P, Li F and Li G:
PAX6, a novel target of microRNA-7, promotes cellular proliferation
and invasion in human colorectal cancer cells. Dig Dis Sci.
59:598–606. 2014. View Article : Google Scholar
|
|
12
|
Ohashi K, Mizuno K, Kuma K, Miyata T and
Nakamura T: Cloning of the cDNA for a novel receptor tyrosine
kinase, Sky, predominantly expressed in brain. Oncogene. 9:699–705.
1994.PubMed/NCBI
|
|
13
|
Schmitz R, Valls AF, Yerbes R, von Richter
S, Kahlert C, Loges S, Weitz J, Schneider M, Ruiz de Almodovar C,
Ulrich A and Schmidt T: TAM receptors Tyro3 and Mer as novel
targets in colorectal cancer. Oncotarget. 7:56355–56370. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vouri M and Hafizi S: TAM receptor
tyrosine kinases in cancer drug resistance. Cancer Res.
77:2775–2778. 2017. View Article : Google Scholar
|
|
15
|
Martinelli E, Martini G, Cardone C,
Troiani T, Liguori G, Vitagliano D, Napolitano S, Morgillo F,
Rinaldi B, Melillo RM, et al: AXL is an oncotarget in human
colorectal cancer. Oncotarget. 6:23281–23296. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kabir TD, Ganda C, Brown RM, Beveridge DJ,
Richardson KL, Chaturvedi V, Candy P, Epis M, Wintle L, Kalinowski
F, et al: A microRNA-7/growth arrest specific 6/TYRO3 axis
regulates the growth and invasiveness of sorafenib-resistant cells
in human hepatocellular carcinoma. Hepatology. 67:216–231. 2018.
View Article : Google Scholar
|
|
17
|
Engelman JA, Luo J and Cantley LC: The
evolution of phosphatidylinositol 3-kinases as regulators of growth
and metabolism. Nat Rev Genet. 7:606–619. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chaturvedi MM, Sung B, Yadav VR, Kannappan
R and Aggarwal BB: NF-κB addiction and its role in cancer: 'One
size does not fit all'. Oncogene. 30:1615–1630. 2011. View Article : Google Scholar
|
|
19
|
Thorson AG, Christensen MA and Davis SJ:
The role of colonoscopy in the assessment of patients with
colorectal cancer. Dis Colon Rectum. 29:306–311. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nagano Y, Toiyama Y, Okugawa Y, Imaoka H,
Fujikawa H, Yasuda H, Yoshiyama S, Hiro J, Kobayashi M, Ohi M, et
al: MicroRNA-7 is associated with malignant potential and poor
prognosis in human colorectal cancer. Anticancer Res. 36:6521–6526.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu K, Chen Z, Qin C and Song X: miR-7
inhibits colorectal cancer cell proliferation and induces apoptosis
by targeting XRCC2. Onco Targets Ther. 7:325–332. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiong S, Zheng Y, Jiang P, Liu R, Liu X
and Chu Y: MicroRNA-7 inhibits the growth of human non-small cell
lung cancer A549 cells through targeting BCL-2. Int J Biol Sci.
7:805–814. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang H, Cai K, Wang J, Wang X, Cheng K,
Shi F, Jiang L, Zhang Y and Dou J: MiR-7, inhibited indirectly by
lincRNA HOTAIR, directly inhibits SETDB1 and reverses the EMT of
breast cancer stem cells by downregulating the STAT 3 pathway. Stem
Cells. 32:2858–2868. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang N, Li X, Wu CW, Dong Y, Cai M, Mok
MT, Wang H, Chen J, Ng SS, Chen M, et al: microRNA-7 is a novel
inhibitor of YY1 contributing to colorectal tumorigenesis.
Oncogene. 32:5078–5088. 2013. View Article : Google Scholar
|
|
26
|
Chien CW, Hou PC, Wu HC, Chang YL, Lin SC,
Lin SC, Lin BW, Lee JC, Chang YJ, Sun HS and Tsai SJ: Targeting
TYRO3 inhibits epithelial-mesenchymal transition and increases drug
sensitivity in colon cancer. Oncogene. 35:5872–5881. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu S, Wurdak H, Wang Y, Galkin A, Tao H,
Li J, Lyssiotis CA, Yan F, Tu BP, Miraglia L, et al: A genomic
screen identifies TYRO3 as a MITF regulator in melanoma. Proc Natl
Acad Sci USA. 106:17025–17030. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gustafsson A, Boström AK, Ljungberg B,
Axelson H and Dahlback B: Gas6 and the receptor tyrosine kinase Axl
in clear cell renal cell carcinoma. PLoS One. 4:e75752009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ou WB, Corson JM, Flynn DL, Lu WP, Wise
SC, Bueno R, Sugarbaker DJ and Fletcher JA: AXL regulates
mesothelioma proliferation and invasiveness. Oncogene.
30:1643–1652. 2011. View Article : Google Scholar
|
|
30
|
Zhong Z, Wang Y, Guo H, Sagare A,
Fernández JA, Bell RD, Barrett TM, Griffin JH, Freeman RS and
Zlokovic BV: Protein S protects neurons from excitotoxic injury by
activating the TAM receptor Tyro3-phosphatidylinositol 3-kinase-Akt
pathway through its sex hormone- binding globulin-like region. J
Neuroscience. 30:15521–15534. 2010. View Article : Google Scholar
|
